O	0	9	Decreased
O	10	13	use
O	14	16	of
O	17	25	adjuvant
O	26	32	breast
O	33	39	cancer
O	40	47	therapy
O	48	50	in
O	51	52	a
O	53	63	randomized
O	64	74	controlled
O	75	80	trial
O	81	83	of
O	84	85	a
B-intervention	86	94	decision
I-intervention	95	98	aid
O	99	103	with
O	104	118	individualized
O	119	123	risk
O	124	135	information
O	135	136	.

O	137	145	Oncology
O	146	154	patients
O	155	160	often
O	161	165	seek
O	166	177	involvement
O	178	180	in
O	181	186	their
O	187	194	medical
O	195	208	consultations
O	208	209	.

O	210	214	Such
O	215	226	involvement
O	227	229	is
O	230	238	endorsed
O	239	241	by
O	242	246	most
O	247	253	health
O	254	258	care
O	259	268	providers
O	269	272	and
O	273	281	mirrored
O	282	284	in
O	285	293	practice
O	294	304	guidelines
O	304	305	.

O	306	313	However
O	313	314	,
O	315	326	oncologists
O	327	334	exhibit
O	335	340	great
O	341	350	variation
O	351	353	in
O	354	357	how
O	358	362	they
O	363	370	provide
O	371	379	patients
O	380	384	with
O	385	392	disease
O	392	393	-
O	393	401	relevant
O	402	413	information
O	413	414	,
O	415	418	and
O	419	423	many
O	424	430	remain
O	431	440	reluctant
O	441	443	to
O	444	446	do
O	447	449	so
O	450	452	at
O	453	456	all
O	456	457	.

O	458	461	The
O	462	469	authors
O	470	478	examined
O	479	482	the
O	483	489	impact
O	490	492	of
O	493	494	a
O	495	502	patient
O	502	503	-
O	503	511	specific
O	512	520	decision
O	521	524	aid
O	525	527	on
O	528	533	women
O	533	534	'
O	534	535	s
O	536	545	decisions
O	546	551	about
O	552	560	adjuvant
O	561	568	therapy
O	569	572	for
O	573	579	breast
O	580	586	cancer
O	586	587	.

B-total-participants	588	591	386
B-eligibility	592	597	women
I-eligibility	598	602	with
I-eligibility	603	609	breast
I-eligibility	610	616	cancer
O	617	621	were
O	622	632	randomized
O	633	635	to
O	636	643	receive
O	644	650	either
O	651	653	an
O	654	667	informational
O	668	676	pamphlet
O	677	682	about
O	683	691	adjuvant
O	692	699	therapy
O	700	701	(
B-control	701	706	usual
I-control	707	711	care
O	711	712	)
O	713	715	or
O	716	717	a
O	718	725	patient
O	725	726	-
O	726	734	specific
O	734	735	,
O	736	744	evidence
O	744	745	-
O	745	750	based
O	751	759	decision
O	760	763	aid
O	764	769	about
O	770	778	adjuvant
O	779	786	therapy
O	786	787	.

O	788	791	The
O	792	799	authors
O	800	808	compared
O	809	814	rates
O	815	817	of
O	818	826	adjuvant
O	827	834	therapy
O	835	842	between
O	843	846	the
O	847	853	groups
O	854	865	controlling
O	866	869	for
O	870	873	age
O	873	874	,
O	875	884	education
O	884	885	,
O	886	893	marital
O	894	900	status
O	900	901	,
O	902	906	race
O	906	907	,
O	908	913	tumor
O	914	922	severity
O	922	923	,
O	924	927	and
O	928	936	practice
O	937	941	type
O	942	944	of
O	945	950	their
O	951	960	physician
O	961	962	(
O	962	972	university
O	972	973	-
O	973	978	based
O	979	981	or
O	982	991	community
O	991	992	-
O	992	997	based
O	997	998	)
O	998	999	.

O	1000	1005	Among
O	1006	1011	women
O	1012	1016	with
O	1017	1020	low
O	1021	1026	tumor
O	1027	1035	severity
O	1035	1036	,
O	1037	1041	only
B-iv-bin-percent	1042	1044	58
I-iv-bin-percent	1044	1045	%
O	1046	1047	(
B-iv-bin-abs	1047	1049	35
O	1049	1050	/
B-intervention-participants	1050	1052	60
O	1052	1053	)
O	1054	1056	of
O	1057	1062	women
O	1063	1065	in
O	1066	1069	the
O	1070	1078	decision
O	1079	1082	aid
O	1083	1088	group
B-outcome	1089	1094	chose
I-outcome	1095	1103	adjuvant
I-outcome	1104	1111	therapy
O	1111	1112	,
O	1113	1121	compared
O	1122	1124	to
B-cv-bin-percent	1125	1127	87
I-cv-bin-percent	1127	1128	%
O	1129	1130	(
B-cv-bin-abs	1130	1132	33
O	1132	1133	/
B-control-participants	1133	1135	38
O	1135	1136	)
O	1137	1139	of
O	1140	1145	their
O	1146	1158	counterparts
O	1159	1161	in
O	1162	1167	usual
O	1168	1172	care
O	1173	1174	(
O	1174	1175	P
O	1175	1176	<
O	1176	1177	0
O	1177	1178	.
O	1178	1180	01
O	1180	1181	)
O	1181	1182	.

O	1183	1187	This
O	1188	1193	study
O	1194	1205	illustrates
O	1206	1209	the
O	1210	1219	important
O	1220	1226	impact
O	1227	1229	of
O	1230	1237	medical
O	1238	1246	decision
O	1247	1251	aids
O	1252	1254	on
O	1255	1264	treatment
O	1265	1272	choices
O	1272	1273	,
O	1274	1286	particularly
O	1287	1290	for
O	1291	1299	patients
O	1300	1303	for
O	1304	1308	whom
O	1309	1318	treatment
O	1319	1322	has
O	1323	1329	little
O	1330	1337	benefit
O	1337	1338	.

O	1339	1341	In
O	1342	1345	the
O	1346	1350	case
O	1351	1353	of
O	1354	1362	adjuvant
O	1363	1370	therapy
O	1371	1374	for
O	1375	1381	breast
O	1382	1388	cancer
O	1388	1389	,
O	1390	1399	providing
O	1400	1414	individualized
O	1414	1415	,
O	1416	1424	evidence
O	1424	1425	-
O	1425	1430	based
O	1431	1435	risk
O	1436	1447	information
O	1448	1451	for
O	1452	1458	shared
O	1459	1467	decision
O	1468	1474	making
O	1475	1483	resulted
O	1484	1486	in
O	1487	1492	fewer
O	1493	1498	women
O	1499	1503	with
O	1504	1507	low
O	1508	1513	tumor
O	1514	1522	severity
O	1523	1531	choosing
O	1532	1540	adjuvant
O	1541	1550	treatment
O	1550	1551	.
